Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethel Cesarman

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Current Opinion in Virology|September 26, 2016
Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?Jennifer Totonchy, Ethel Cesarman
Cell Host & Microbe|December 20, 2011
Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3DEnrique A Mesri, Ethel Cesarman
Current Opinion in Virology|November 7, 2017
Editorial overview: Viruses and cancer: How tumor viruses affect the cellular genomeThomas F Schulz, Ethel Cesarman
Genome Biology|November 13, 2004
Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysisDaniel Di Bartolo, Ethel Cesarman
Cancer Treatment and Research|May 18, 2006
Pathogenesis of viral lymphomasEthel Cesarman, Enrique A Mesri
Current Topics in Microbiology and Immunology|September 17, 2010
NF-κB as a target for oncogenic virusesShao-Cong Sun, Ethel Cesarman
Current Opinion in Virology|October 4, 2015
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesisThomas F Schulz, Ethel Cesarman
EMBO Reports|November 29, 2005
The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signallingIlaria Guasparri, Hao Wu, Ethel Cesarman
Blood|September 10, 2005
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2Mark Cannon, Ethel Cesarman, Chris Boshoff
Lab on a Chip|August 14, 2014
Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessoryMatthew Mancuso, Ethel Cesarman, David Erickson
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Current Opinion in Virology|September 26, 2016
Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?Jennifer Totonchy, Ethel Cesarman
Cell Host & Microbe|December 20, 2011
Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3DEnrique A Mesri, Ethel Cesarman
Current Opinion in Virology|November 7, 2017
Editorial overview: Viruses and cancer: How tumor viruses affect the cellular genomeThomas F Schulz, Ethel Cesarman
Genome Biology|November 13, 2004
Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysisDaniel Di Bartolo, Ethel Cesarman
Cancer Treatment and Research|May 18, 2006
Pathogenesis of viral lymphomasEthel Cesarman, Enrique A Mesri
Current Topics in Microbiology and Immunology|September 17, 2010
NF-κB as a target for oncogenic virusesShao-Cong Sun, Ethel Cesarman
Current Opinion in Virology|October 4, 2015
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesisThomas F Schulz, Ethel Cesarman
EMBO Reports|November 29, 2005
The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signallingIlaria Guasparri, Hao Wu, Ethel Cesarman
Blood|September 10, 2005
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2Mark Cannon, Ethel Cesarman, Chris Boshoff
Lab on a Chip|August 14, 2014
Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessoryMatthew Mancuso, Ethel Cesarman, David Erickson
Pageof 15